Found: 4
Select item for more details and to access through your institution.
Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0023379
- By:
- Publication type:
- Article
Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Comparison of three rapamycin dosing schedules in A/J Tsc2<sup>+/-</sup> mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors.
- Published in:
- Journal of Translational Medicine, 2010, v. 8, p. 14, doi. 10.1186/1479-5876-8-14
- By:
- Publication type:
- Article
Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models.
- Published in:
- BMC Pharmacology, 2009, v. 9, p. 1, doi. 10.1186/1471-2210-9-8
- By:
- Publication type:
- Article